Home > > > Report Detail

Covid-19 Impact on Global Nasal Drug Delivery Technology Market Insights, Forecast to 2026

Publisher Name :
Date: 12-May-2020
No. of pages: 150
Inquire Before Buying

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nasal Drug Delivery Technology market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Nasal Drug Delivery Technology industry.

Based on our recent survey, we have several different scenarios about the Nasal Drug Delivery Technology YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Nasal Drug Delivery Technology will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nasal Drug Delivery Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nasal Drug Delivery Technology market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Nasal Drug Delivery Technology market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Nasal Drug Delivery Technology market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Nasal Drug Delivery Technology market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Nasal Drug Delivery Technology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nasal Drug Delivery Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nasal Drug Delivery Technology market.

The following manufacturers are covered in this report:

- 3M United States

- Aegis Therapeutics LLC

- Aptargroup, Inc.

- Becton, Dickinson and Company

- BF Ascher & Company, Inc.

- Cadila Pharmaceuticals Ltd

- Dickinson and Company

- Douglas Pharmaceuticals Ltd

- ENT Technologies Pty. Ltd

- Glaxosmithkline PLC

- Johnson & Johnson

- Merck & Co., Inc.

- Novartis AG

- OptiNose, Inc

- PendoPharm, Inc

- Pfizer, Inc

- Promius Pharma, LLC

- Shin Nippon Biomedical Laboratories

Nasal Drug Delivery Technology Breakdown Data by Type

- Pressurized Type

- Non-pressurized Type

Nasal Drug Delivery Technology Breakdown Data by Application

- Nasal Congestion

- Rhinitis

- Asthma

- Other

Covid-19 Impact on Global Nasal Drug Delivery Technology Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Nasal Drug Delivery Technology Product Introduction
1.2 Market Segments
1.3 Key Nasal Drug Delivery Technology Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nasal Drug Delivery Technology Market Size Growth Rate by Type
1.4.2 Pressurized Type
1.4.3 Non-pressurized Type
1.5 Market by Application
1.5.1 Global Nasal Drug Delivery Technology Market Size Growth Rate by Application
1.5.2 Nasal Congestion
1.5.3 Rhinitis
1.5.4 Asthma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Nasal Drug Delivery Technology Industry Impact
1.6.1 How the Covid-19 is Affecting the Nasal Drug Delivery Technology Industry
1.6.1.1 Nasal Drug Delivery Technology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nasal Drug Delivery Technology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nasal Drug Delivery Technology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Nasal Drug Delivery Technology Market Size Estimates and Forecasts
2.1.1 Global Nasal Drug Delivery Technology Revenue 2015-2026
2.1.2 Global Nasal Drug Delivery Technology Sales 2015-2026
2.2 Nasal Drug Delivery Technology Market Size by Region: 2020 Versus 2026
2.2.1 Global Nasal Drug Delivery Technology Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nasal Drug Delivery Technology Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Nasal Drug Delivery Technology Competitor Landscape by Players
3.1 Nasal Drug Delivery Technology Sales by Manufacturers
3.1.1 Nasal Drug Delivery Technology Sales by Manufacturers (2015-2020)
3.1.2 Nasal Drug Delivery Technology Sales Market Share by Manufacturers (2015-2020)
3.2 Nasal Drug Delivery Technology Revenue by Manufacturers
3.2.1 Nasal Drug Delivery Technology Revenue by Manufacturers (2015-2020)
3.2.2 Nasal Drug Delivery Technology Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nasal Drug Delivery Technology Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nasal Drug Delivery Technology Revenue in 2019
3.2.5 Global Nasal Drug Delivery Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nasal Drug Delivery Technology Price by Manufacturers
3.4 Nasal Drug Delivery Technology Manufacturing Base Distribution, Product Types
3.4.1 Nasal Drug Delivery Technology Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nasal Drug Delivery Technology Product Type
3.4.3 Date of International Manufacturers Enter into Nasal Drug Delivery Technology Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Nasal Drug Delivery Technology Market Size by Type (2015-2020)
4.1.1 Global Nasal Drug Delivery Technology Sales by Type (2015-2020)
4.1.2 Global Nasal Drug Delivery Technology Revenue by Type (2015-2020)
4.1.3 Nasal Drug Delivery Technology Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nasal Drug Delivery Technology Market Size Forecast by Type (2021-2026)
4.2.1 Global Nasal Drug Delivery Technology Sales Forecast by Type (2021-2026)
4.2.2 Global Nasal Drug Delivery Technology Revenue Forecast by Type (2021-2026)
4.2.3 Nasal Drug Delivery Technology Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nasal Drug Delivery Technology Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Nasal Drug Delivery Technology Market Size by Application (2015-2020)
5.1.1 Global Nasal Drug Delivery Technology Sales by Application (2015-2020)
5.1.2 Global Nasal Drug Delivery Technology Revenue by Application (2015-2020)
5.1.3 Nasal Drug Delivery Technology Price by Application (2015-2020)
5.2 Nasal Drug Delivery Technology Market Size Forecast by Application (2021-2026)
5.2.1 Global Nasal Drug Delivery Technology Sales Forecast by Application (2021-2026)
5.2.2 Global Nasal Drug Delivery Technology Revenue Forecast by Application (2021-2026)
5.2.3 Global Nasal Drug Delivery Technology Price Forecast by Application (2021-2026)
6 North America
6.1 North America Nasal Drug Delivery Technology by Country
6.1.1 North America Nasal Drug Delivery Technology Sales by Country
6.1.2 North America Nasal Drug Delivery Technology Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nasal Drug Delivery Technology Market Facts & Figures by Type
6.3 North America Nasal Drug Delivery Technology Market Facts & Figures by Application
7 Europe
7.1 Europe Nasal Drug Delivery Technology by Country
7.1.1 Europe Nasal Drug Delivery Technology Sales by Country
7.1.2 Europe Nasal Drug Delivery Technology Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nasal Drug Delivery Technology Market Facts & Figures by Type
7.3 Europe Nasal Drug Delivery Technology Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Nasal Drug Delivery Technology by Region
8.1.1 Asia Pacific Nasal Drug Delivery Technology Sales by Region
8.1.2 Asia Pacific Nasal Drug Delivery Technology Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nasal Drug Delivery Technology Market Facts & Figures by Type
8.3 Asia Pacific Nasal Drug Delivery Technology Market Facts & Figures by Application
9 Latin America
9.1 Latin America Nasal Drug Delivery Technology by Country
9.1.1 Latin America Nasal Drug Delivery Technology Sales by Country
9.1.2 Latin America Nasal Drug Delivery Technology Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nasal Drug Delivery Technology Market Facts & Figures by Type
9.3 Central & South America Nasal Drug Delivery Technology Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Nasal Drug Delivery Technology by Country
10.1.1 Middle East and Africa Nasal Drug Delivery Technology Sales by Country
10.1.2 Middle East and Africa Nasal Drug Delivery Technology Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nasal Drug Delivery Technology Market Facts & Figures by Type
10.3 Middle East and Africa Nasal Drug Delivery Technology Market Facts & Figures by Application
11 Company Profiles
11.1 3M United States
11.1.1 3M United States Corporation Information
11.1.2 3M United States Description, Business Overview and Total Revenue
11.1.3 3M United States Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3M United States Nasal Drug Delivery Technology Products Offered
11.1.5 3M United States Recent Development
11.2 Aegis Therapeutics LLC
11.2.1 Aegis Therapeutics LLC Corporation Information
11.2.2 Aegis Therapeutics LLC Description, Business Overview and Total Revenue
11.2.3 Aegis Therapeutics LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Products Offered
11.2.5 Aegis Therapeutics LLC Recent Development
11.3 Aptargroup, Inc.
11.3.1 Aptargroup, Inc. Corporation Information
11.3.2 Aptargroup, Inc. Description, Business Overview and Total Revenue
11.3.3 Aptargroup, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aptargroup, Inc. Nasal Drug Delivery Technology Products Offered
11.3.5 Aptargroup, Inc. Recent Development
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Corporation Information
11.4.2 Becton, Dickinson and Company Description, Business Overview and Total Revenue
11.4.3 Becton, Dickinson and Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Products Offered
11.4.5 Becton, Dickinson and Company Recent Development
11.5 BF Ascher & Company, Inc.
11.5.1 BF Ascher & Company, Inc. Corporation Information
11.5.2 BF Ascher & Company, Inc. Description, Business Overview and Total Revenue
11.5.3 BF Ascher & Company, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Products Offered
11.5.5 BF Ascher & Company, Inc. Recent Development
11.6 Cadila Pharmaceuticals Ltd
11.6.1 Cadila Pharmaceuticals Ltd Corporation Information
11.6.2 Cadila Pharmaceuticals Ltd Description, Business Overview and Total Revenue
11.6.3 Cadila Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Products Offered
11.6.5 Cadila Pharmaceuticals Ltd Recent Development
11.7 Dickinson and Company
11.7.1 Dickinson and Company Corporation Information
11.7.2 Dickinson and Company Description, Business Overview and Total Revenue
11.7.3 Dickinson and Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dickinson and Company Nasal Drug Delivery Technology Products Offered
11.7.5 Dickinson and Company Recent Development
11.8 Douglas Pharmaceuticals Ltd
11.8.1 Douglas Pharmaceuticals Ltd Corporation Information
11.8.2 Douglas Pharmaceuticals Ltd Description, Business Overview and Total Revenue
11.8.3 Douglas Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Products Offered
11.8.5 Douglas Pharmaceuticals Ltd Recent Development
11.9 ENT Technologies Pty. Ltd
11.9.1 ENT Technologies Pty. Ltd Corporation Information
11.9.2 ENT Technologies Pty. Ltd Description, Business Overview and Total Revenue
11.9.3 ENT Technologies Pty. Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Products Offered
11.9.5 ENT Technologies Pty. Ltd Recent Development
11.10 Glaxosmithkline PLC
11.10.1 Glaxosmithkline PLC Corporation Information
11.10.2 Glaxosmithkline PLC Description, Business Overview and Total Revenue
11.10.3 Glaxosmithkline PLC Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Products Offered
11.10.5 Glaxosmithkline PLC Recent Development
11.1 3M United States
11.1.1 3M United States Corporation Information
11.1.2 3M United States Description, Business Overview and Total Revenue
11.1.3 3M United States Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3M United States Nasal Drug Delivery Technology Products Offered
11.1.5 3M United States Recent Development
11.12 Merck & Co., Inc.
11.12.1 Merck & Co., Inc. Corporation Information
11.12.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
11.12.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Merck & Co., Inc. Products Offered
11.12.5 Merck & Co., Inc. Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Corporation Information
11.13.2 Novartis AG Description, Business Overview and Total Revenue
11.13.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Novartis AG Products Offered
11.13.5 Novartis AG Recent Development
11.14 OptiNose, Inc
11.14.1 OptiNose, Inc Corporation Information
11.14.2 OptiNose, Inc Description, Business Overview and Total Revenue
11.14.3 OptiNose, Inc Sales, Revenue and Gross Margin (2015-2020)
11.14.4 OptiNose, Inc Products Offered
11.14.5 OptiNose, Inc Recent Development
11.15 PendoPharm, Inc
11.15.1 PendoPharm, Inc Corporation Information
11.15.2 PendoPharm, Inc Description, Business Overview and Total Revenue
11.15.3 PendoPharm, Inc Sales, Revenue and Gross Margin (2015-2020)
11.15.4 PendoPharm, Inc Products Offered
11.15.5 PendoPharm, Inc Recent Development
11.16 Pfizer, Inc
11.16.1 Pfizer, Inc Corporation Information
11.16.2 Pfizer, Inc Description, Business Overview and Total Revenue
11.16.3 Pfizer, Inc Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Pfizer, Inc Products Offered
11.16.5 Pfizer, Inc Recent Development
11.17 Promius Pharma, LLC
11.17.1 Promius Pharma, LLC Corporation Information
11.17.2 Promius Pharma, LLC Description, Business Overview and Total Revenue
11.17.3 Promius Pharma, LLC Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Promius Pharma, LLC Products Offered
11.17.5 Promius Pharma, LLC Recent Development
11.18 Shin Nippon Biomedical Laboratories
11.18.1 Shin Nippon Biomedical Laboratories Corporation Information
11.18.2 Shin Nippon Biomedical Laboratories Description, Business Overview and Total Revenue
11.18.3 Shin Nippon Biomedical Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Shin Nippon Biomedical Laboratories Products Offered
11.18.5 Shin Nippon Biomedical Laboratories Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Nasal Drug Delivery Technology Market Estimates and Projections by Region
12.1.1 Global Nasal Drug Delivery Technology Sales Forecast by Regions 2021-2026
12.1.2 Global Nasal Drug Delivery Technology Revenue Forecast by Regions 2021-2026
12.2 North America Nasal Drug Delivery Technology Market Size Forecast (2021-2026)
12.2.1 North America: Nasal Drug Delivery Technology Sales Forecast (2021-2026)
12.2.2 North America: Nasal Drug Delivery Technology Revenue Forecast (2021-2026)
12.2.3 North America: Nasal Drug Delivery Technology Market Size Forecast by Country (2021-2026)
12.3 Europe Nasal Drug Delivery Technology Market Size Forecast (2021-2026)
12.3.1 Europe: Nasal Drug Delivery Technology Sales Forecast (2021-2026)
12.3.2 Europe: Nasal Drug Delivery Technology Revenue Forecast (2021-2026)
12.3.3 Europe: Nasal Drug Delivery Technology Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nasal Drug Delivery Technology Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nasal Drug Delivery Technology Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nasal Drug Delivery Technology Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nasal Drug Delivery Technology Market Size Forecast by Region (2021-2026)
12.5 Latin America Nasal Drug Delivery Technology Market Size Forecast (2021-2026)
12.5.1 Latin America: Nasal Drug Delivery Technology Sales Forecast (2021-2026)
12.5.2 Latin America: Nasal Drug Delivery Technology Revenue Forecast (2021-2026)
12.5.3 Latin America: Nasal Drug Delivery Technology Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nasal Drug Delivery Technology Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nasal Drug Delivery Technology Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nasal Drug Delivery Technology Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nasal Drug Delivery Technology Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Nasal Drug Delivery Technology Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nasal Drug Delivery Technology Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Nasal Drug Delivery Technology Market Segments
Table 2. Ranking of Global Top Nasal Drug Delivery Technology Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nasal Drug Delivery Technology Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Pressurized Type
Table 5. Major Manufacturers of Non-pressurized Type
Table 6. COVID-19 Impact Global Market: (Four Nasal Drug Delivery Technology Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Nasal Drug Delivery Technology Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Nasal Drug Delivery Technology Players to Combat Covid-19 Impact
Table 11. Global Nasal Drug Delivery Technology Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Nasal Drug Delivery Technology Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Nasal Drug Delivery Technology Sales by Regions 2015-2020 (K Units)
Table 14. Global Nasal Drug Delivery Technology Sales Market Share by Regions (2015-2020)
Table 15. Global Nasal Drug Delivery Technology Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Nasal Drug Delivery Technology Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Nasal Drug Delivery Technology Sales Share by Manufacturers (2015-2020)
Table 18. Global Nasal Drug Delivery Technology Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Nasal Drug Delivery Technology by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Drug Delivery Technology as of 2019)
Table 20. Nasal Drug Delivery Technology Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Nasal Drug Delivery Technology Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Nasal Drug Delivery Technology Price (2015-2020) (USD/Unit)
Table 23. Nasal Drug Delivery Technology Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nasal Drug Delivery Technology Product Type
Table 25. Date of International Manufacturers Enter into Nasal Drug Delivery Technology Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Nasal Drug Delivery Technology Sales by Type (2015-2020) (K Units)
Table 28. Global Nasal Drug Delivery Technology Sales Share by Type (2015-2020)
Table 29. Global Nasal Drug Delivery Technology Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Nasal Drug Delivery Technology Revenue Share by Type (2015-2020)
Table 31. Nasal Drug Delivery Technology Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Nasal Drug Delivery Technology Sales by Application (2015-2020) (K Units)
Table 33. Global Nasal Drug Delivery Technology Sales Share by Application (2015-2020)
Table 34. North America Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 35. North America Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 36. North America Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 38. North America Nasal Drug Delivery Technology Sales by Type (2015-2020) (K Units)
Table 39. North America Nasal Drug Delivery Technology Sales Market Share by Type (2015-2020)
Table 40. North America Nasal Drug Delivery Technology Sales by Application (2015-2020) (K Units)
Table 41. North America Nasal Drug Delivery Technology Sales Market Share by Application (2015-2020)
Table 42. Europe Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 43. Europe Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 44. Europe Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 46. Europe Nasal Drug Delivery Technology Sales by Type (2015-2020) (K Units)
Table 47. Europe Nasal Drug Delivery Technology Sales Market Share by Type (2015-2020)
Table 48. Europe Nasal Drug Delivery Technology Sales by Application (2015-2020) (K Units)
Table 49. Europe Nasal Drug Delivery Technology Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Nasal Drug Delivery Technology Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Nasal Drug Delivery Technology Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Nasal Drug Delivery Technology Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Nasal Drug Delivery Technology Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Nasal Drug Delivery Technology Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Nasal Drug Delivery Technology Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Nasal Drug Delivery Technology Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Nasal Drug Delivery Technology Sales Market Share by Application (2015-2020)
Table 58. Latin America Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 59. Latin America Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 62. Latin America Nasal Drug Delivery Technology Sales by Type (2015-2020) (K Units)
Table 63. Latin America Nasal Drug Delivery Technology Sales Market Share by Type (2015-2020)
Table 64. Latin America Nasal Drug Delivery Technology Sales by Application (2015-2020) (K Units)
Table 65. Latin America Nasal Drug Delivery Technology Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nasal Drug Delivery Technology Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Nasal Drug Delivery Technology Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Nasal Drug Delivery Technology Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Nasal Drug Delivery Technology Sales Market Share by Application (2015-2020)
Table 74. 3M United States Corporation Information
Table 75. 3M United States Description and Major Businesses
Table 76. 3M United States Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. 3M United States Product
Table 78. 3M United States Recent Development
Table 79. Aegis Therapeutics LLC Corporation Information
Table 80. Aegis Therapeutics LLC Description and Major Businesses
Table 81. Aegis Therapeutics LLC Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Aegis Therapeutics LLC Product
Table 83. Aegis Therapeutics LLC Recent Development
Table 84. Aptargroup, Inc. Corporation Information
Table 85. Aptargroup, Inc. Description and Major Businesses
Table 86. Aptargroup, Inc. Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Aptargroup, Inc. Product
Table 88. Aptargroup, Inc. Recent Development
Table 89. Becton, Dickinson and Company Corporation Information
Table 90. Becton, Dickinson and Company Description and Major Businesses
Table 91. Becton, Dickinson and Company Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Becton, Dickinson and Company Product
Table 93. Becton, Dickinson and Company Recent Development
Table 94. BF Ascher & Company, Inc. Corporation Information
Table 95. BF Ascher & Company, Inc. Description and Major Businesses
Table 96. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. BF Ascher & Company, Inc. Product
Table 98. BF Ascher & Company, Inc. Recent Development
Table 99. Cadila Pharmaceuticals Ltd Corporation Information
Table 100. Cadila Pharmaceuticals Ltd Description and Major Businesses
Table 101. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Cadila Pharmaceuticals Ltd Product
Table 103. Cadila Pharmaceuticals Ltd Recent Development
Table 104. Dickinson and Company Corporation Information
Table 105. Dickinson and Company Description and Major Businesses
Table 106. Dickinson and Company Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Dickinson and Company Product
Table 108. Dickinson and Company Recent Development
Table 109. Douglas Pharmaceuticals Ltd Corporation Information
Table 110. Douglas Pharmaceuticals Ltd Description and Major Businesses
Table 111. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Douglas Pharmaceuticals Ltd Product
Table 113. Douglas Pharmaceuticals Ltd Recent Development
Table 114. ENT Technologies Pty. Ltd Corporation Information
Table 115. ENT Technologies Pty. Ltd Description and Major Businesses
Table 116. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. ENT Technologies Pty. Ltd Product
Table 118. ENT Technologies Pty. Ltd Recent Development
Table 119. Glaxosmithkline PLC Corporation Information
Table 120. Glaxosmithkline PLC Description and Major Businesses
Table 121. Glaxosmithkline PLC Nasal Drug Delivery Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Glaxosmithkline PLC Product
Table 123. Glaxosmithkline PLC Recent Development
Table 124. Johnson & Johnson Corporation Information
Table 125. Johnson & Johnson Description and Major Businesses
Table 126. Johnson & Johnson Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Johnson & Johnson Product
Table 128. Johnson & Johnson Recent Development
Table 129. Merck & Co., Inc. Corporation Information
Table 130. Merck & Co., Inc. Description and Major Businesses
Table 131. Merck & Co., Inc. Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Merck & Co., Inc. Product
Table 133. Merck & Co., Inc. Recent Development
Table 134. Novartis AG Corporation Information
Table 135. Novartis AG Description and Major Businesses
Table 136. Novartis AG Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Novartis AG Product
Table 138. Novartis AG Recent Development
Table 139. OptiNose, Inc Corporation Information
Table 140. OptiNose, Inc Description and Major Businesses
Table 141. OptiNose, Inc Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. OptiNose, Inc Product
Table 143. OptiNose, Inc Recent Development
Table 144. PendoPharm, Inc Corporation Information
Table 145. PendoPharm, Inc Description and Major Businesses
Table 146. PendoPharm, Inc Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. PendoPharm, Inc Product
Table 148. PendoPharm, Inc Recent Development
Table 149. Pfizer, Inc Corporation Information
Table 150. Pfizer, Inc Description and Major Businesses
Table 151. Pfizer, Inc Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Pfizer, Inc Product
Table 153. Pfizer, Inc Recent Development
Table 154. Promius Pharma, LLC Corporation Information
Table 155. Promius Pharma, LLC Description and Major Businesses
Table 156. Promius Pharma, LLC Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Promius Pharma, LLC Product
Table 158. Promius Pharma, LLC Recent Development
Table 159. Shin Nippon Biomedical Laboratories Corporation Information
Table 160. Shin Nippon Biomedical Laboratories Description and Major Businesses
Table 161. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Shin Nippon Biomedical Laboratories Product
Table 163. Shin Nippon Biomedical Laboratories Recent Development
Table 164. Global Nasal Drug Delivery Technology Sales Forecast by Regions (2021-2026) (K Units)
Table 165. Global Nasal Drug Delivery Technology Sales Market Share Forecast by Regions (2021-2026)
Table 166. Global Nasal Drug Delivery Technology Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 167. Global Nasal Drug Delivery Technology Revenue Market Share Forecast by Regions (2021-2026)
Table 168. North America: Nasal Drug Delivery Technology Sales Forecast by Country (2021-2026) (K Units)
Table 169. North America: Nasal Drug Delivery Technology Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Europe: Nasal Drug Delivery Technology Sales Forecast by Country (2021-2026) (K Units)
Table 171. Europe: Nasal Drug Delivery Technology Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Asia Pacific: Nasal Drug Delivery Technology Sales Forecast by Region (2021-2026) (K Units)
Table 173. Asia Pacific: Nasal Drug Delivery Technology Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Latin America: Nasal Drug Delivery Technology Sales Forecast by Country (2021-2026) (K Units)
Table 175. Latin America: Nasal Drug Delivery Technology Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Middle East and Africa: Nasal Drug Delivery Technology Sales Forecast by Country (2021-2026) (K Units)
Table 177. Middle East and Africa: Nasal Drug Delivery Technology Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Market Risks
Table 181. Main Points Interviewed from Key Nasal Drug Delivery Technology Players
Table 182. Nasal Drug Delivery Technology Customers List
Table 183. Nasal Drug Delivery Technology Distributors List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasal Drug Delivery Technology Product Picture
Figure 2. Global Nasal Drug Delivery Technology Sales Market Share by Type in 2020 & 2026
Figure 3. Pressurized Type Product Picture
Figure 4. Non-pressurized Type Product Picture
Figure 5. Global Nasal Drug Delivery Technology Sales Market Share by Application in 2020 & 2026
Figure 6. Nasal Congestion
Figure 7. Rhinitis
Figure 8. Asthma
Figure 9. Other
Figure 10. Nasal Drug Delivery Technology Report Years Considered
Figure 11. Global Nasal Drug Delivery Technology Market Size 2015-2026 (US$ Million)
Figure 12. Global Nasal Drug Delivery Technology Sales 2015-2026 (K Units)
Figure 13. Global Nasal Drug Delivery Technology Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Nasal Drug Delivery Technology Sales Market Share by Region (2015-2020)
Figure 15. Global Nasal Drug Delivery Technology Sales Market Share by Region in 2019
Figure 16. Global Nasal Drug Delivery Technology Revenue Market Share by Region (2015-2020)
Figure 17. Global Nasal Drug Delivery Technology Revenue Market Share by Region in 2019
Figure 18. Global Nasal Drug Delivery Technology Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Nasal Drug Delivery Technology Revenue in 2019
Figure 20. Nasal Drug Delivery Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs